GEODE CAPITAL MANAGEMENT, LLC - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 21 filers reported holding HEMISPHERX BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q1 2019$11,000
-57.7%
74,832
-50.0%
0.00%
Q4 2018$26,000
+52.9%
149,664
+100.0%
0.00%
Q3 2018$17,000
-26.1%
74,8320.0%0.00%
Q2 2018$23,000
-20.7%
74,8320.0%0.00%
Q1 2018$29,000
+16.0%
74,8320.0%0.00%
Q4 2017$25,000
+4.2%
74,8320.0%0.00%
Q3 2017$24,000
-35.1%
74,8320.0%0.00%
Q2 2017$37,000
-7.5%
74,8320.0%0.00%
Q1 2017$40,000
-21.6%
74,8320.0%0.00%
Q4 2016$51,000
-45.2%
74,832
+0.0%
0.00%
Q3 2016$93,00074,8310.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
Virtu Financial LLC 67,719$11,0000.00%
Occidental Asset Management, LLC 15,834$3,0000.00%
VANGUARD GROUP INC 361,415$58,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 2,080$00.00%
Sound Income Strategies, LLC 9$00.00%
HUNTINGTON NATIONAL BANK 2,501$00.00%
CITY HOLDING CO 417$00.00%
NORTHERN TRUST CORP 31,933$5,0000.00%
Waldron Private Wealth LLC 11,000$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders